94 related articles for article (PubMed ID: 3904416)
21. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.
Bajaj MS; Rana SV; Wysolmerski RB; Bajaj SP
J Clin Invest; 1987 Jun; 79(6):1874-8. PubMed ID: 3034984
[TBL] [Abstract][Full Text] [Related]
22. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
23. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
[TBL] [Abstract][Full Text] [Related]
24. The role of tissue thromboplastin in the development of DIC accompanying neoplastic diseases.
Gonmori H; Maekawa T; Kobayashi N; Tanaka H; Tsukada H; Takada M; Andou K
Bibl Haematol; 1983; (49):23-39. PubMed ID: 6667248
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
26. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
27. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
[TBL] [Abstract][Full Text] [Related]
29. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
30. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
32. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
33. Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172.
Nieuwenhuis HK; Sixma JJ
Cancer; 1986 Aug; 58(3):761-4. PubMed ID: 2425925
[TBL] [Abstract][Full Text] [Related]
34. Role of tissue factor in disseminated intravascular coagulation.
Asakura H; Kamikubo Y; Goto A; Shiratori Y; Yamazaki M; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E
Thromb Res; 1995 Nov; 80(3):217-24. PubMed ID: 8578548
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
Bevilacqua MP; Pober JS; Majeau GR; Cotran RS; Gimbrone MA
J Exp Med; 1984 Aug; 160(2):618-23. PubMed ID: 6332168
[TBL] [Abstract][Full Text] [Related]
36. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
37. Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells.
Berdel WE; Kulimova E; Kolkmeyer A; Zühlsdorf M; Serve H; Büchner T; Oelmann E
Ann Hematol; 2005 Nov; 84(12):771-3. PubMed ID: 16094532
[TBL] [Abstract][Full Text] [Related]
38. Chemotactic factor binding and functional capacity: a comparison between human granulocytes and differentiated HL-60 cells.
Dahlgren C; Andersson T; Stendahl O
J Leukoc Biol; 1987 Sep; 42(3):245-52. PubMed ID: 3040876
[TBL] [Abstract][Full Text] [Related]
39. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells.
Collins SJ; Bodner A; Ting R; Gallo RC
Int J Cancer; 1980 Feb; 25(2):213-8. PubMed ID: 6156128
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of monocyte procoagulant activity by adherence to different surfaces.
van Ginkel CJ; van Aken WG; Oh JI; Vreeken J
Br J Haematol; 1977 Sep; 37(1):35-45. PubMed ID: 588477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
